Stromecki, M., Tatari, N., Morrison, L. C., Kaur, R., Zagozewski, J., Palidwor, G., . . . Werbowetski‐Ogilvie, T. E. (2018). Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Mol Oncol.
Chicago ZitierstilStromecki, Margaret, et al. "Characterization of a Novel OTX2‐driven Stem Cell Program in Group 3 and Group 4 Medulloblastoma." Mol Oncol 2018.
MLA ZitierstilStromecki, Margaret, et al. "Characterization of a Novel OTX2‐driven Stem Cell Program in Group 3 and Group 4 Medulloblastoma." Mol Oncol 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.